Earnings History Data for Entrada Therapeutics, Inc. (TRDA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Entrada Therapeutics, Inc.
Entrada Therapeutics Inc. is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles(TM) to engage intracellular targets. Entrada Therapeutics Inc. is based in BOSTON.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-05-2024 | PM | TRDA | Entrada Therapeutics | 443.00 | 0.68 | -0.38 | 0.00 | Entrada Therapeutics GAAP EPS of $0.68, revenue of $59.12M [5/7/2024 7:50 AM] |
13.93 | 0.43 (3.19%) |
14.20 | 0.70 (5.19%) |
10.62 - 18.44 | 32,157 | 50,000 | 273 | ||
| 13-03-2024 | PM | TRDA | Entrada Therapeutics | 392.00 | -0.29 | -0.07 | 0.00 | 12.67 | 1.09 (9.41%) |
0.0 | 0.0 (0.00%) |
10.62 - 18.44 | 144,666 | 90,000 | 0 | |||
|
|
||||||||||||||||||
| 07-11-2023 | PM | TRDA | Entrada Therapeutics, Inc. | 521.36 | 1.02 | -0.55 | -0.80 | Entrada Therapeutics GAAP EPS of $1.02, revenue of $43.74M [11/7/2023 8:37 AM] |
16.94 | 1.30 (8.31%) |
15.64 | 0.0 (0.00%) |
9.32 - 22.00 | 58,773 | 40,000 | 905 | ||
| 08-08-2023 | PM | TRDA | Entrada Therapeutics | 473.00 | -0.78 | -0.43 | 0.00 | Entrada Therapeutics GAAP EPS of -$0.78, revenue of $18.2M [8/8/2023 10:17 AM] |
15.31 | 1.37 (9.83%) |
0.0 | 0.0 (0.00%) |
9.32 - 24.38 | 53,249 | 40,000 | 0 | ||
| 10-05-2023 | PM | TRDA | Entrada Therapeutics | 385.00 | -0.21 | -0.77 | 0.00 | Entrada Therapeutics GAAP EPS of -$0.21, revenue of $25.26M [5/10/2023 1:51 PM] |
11.88 | -0.31 (-2.52%) |
0.0 | 0.0 (0.00%) |
5.43 - 24.38 | 63,651 | 50,000 | 0 | ||
| 06-03-2023 | PM | TRDA | Entrada Therapeutics | 319.00 | -0.79 | -0.84 | 0.00 | Entrada Therapeutics GAAP EPS of -$0.79 beats by $0.04 [3/6/2023 7:26 AM] |
10.34 | -0.29 (-2.73%) |
0.0 | 0.0 (0.00%) |
5.12 - 24.38 | 25,217 | 40,000 | 0 | ||